Skip to main content

Study

MemoVigor 2 May Help Reduce Tinnitus Symptoms in Older Adults

Taking MemoVigor 2 daily for 3 months showed promise in alleviating tinnitus symptoms in seniors.

Hearing HealthHealthy AgingMemory Support
Study Credibility: Medium5.6/10Some supporting evidenceStudy has limitationsUse with caution
PublishedJan 2026DesignClinical TrialLast reviewedJun 2026
Email this

Summary

In plain language

This study explored whether MemoVigor 2, a dietary supplement, could help alleviate symptoms of tinnitus—a persistent ringing in the ears. Seniors with tinnitus participated in a 3-month trial where they were given either MemoVigor 2 or a placebo. The findings suggest that those who took MemoVigor 2 experienced some relief in their tinnitus symptoms. This is encouraging news for seniors seeking alternative options for managing tinnitus, a common issue in older age. It's important to discuss these findings with your healthcare provider to see if this supplement might be beneficial for you.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study investigated the effects of MemoVigor 2 on tinnitus symptoms in older adults. Participants were randomly assigned to take either MemoVigor 2 or a placebo for 3 months. Researchers found that those who took MemoVigor 2 reported an improvement in their symptoms.

  • The study used a randomized, double-blind design, meaning neither participants nor researchers knew who received the actual supplement.

  • Key ingredients in MemoVigor 2 include phospholipids, vitamins, and plant extracts like Ginkgo biloba and Bilberry, which may support brain and ear health.

  • While promising, these results should be considered preliminary and discussed with your healthcare provider before starting any new supplement.

Always consult with your healthcare provider before making changes to your health regimen.

Research Quality Score

Scored June 24, 2026 using rubric mq-1.5_2026-06-18.

Assessment

The study's strengths include its randomized controlled design with proper blinding and allocation concealment. However, it lacks transparency in reporting and COI disclosure, and the journal quality is unassessable. Statistical methods are not fully detailed, and no replication evidence is provided.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control10.0/10
Statistical methods5.0/10
Reporting completeness5.0/10
Conflicts & funding0.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability0.0/10

Additional Notes

The study evaluates the effect of MemoVigor 2 on tinnitus symptoms in older adults using a randomized, placebo-controlled trial design.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were checked.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.